|
Orthologous residues
|
|
MRE11A (human): S264‑p, MRE11A iso2 (human): S264‑p, MRE11A (mouse): S264‑p, MRE11A (rat): S264‑p
|
|
Characterization
|
|
Methods used to characterize site in vivo:
electrophoretic mobility shift, immunoprecipitation, mutation of modification site
|
|
Relevant cell lines - cell types - tissues:
oocyte
|
|
Cellular systems studied:
primary cells
|
|
Species studied:
frog
|
|
Comments:
based on mutation of multiple sites
|
|
Upstream Regulation
|
|
Treatments, proteins and their effect on site modification:
|
|
Treatments
|
Referenced Treatments
|
Manipulated Protein
|
Referenced Protein
|
Effect
|
Notes
|
|
DSBs, okadaic acid
|
|
|
|
increase
|
|
|
caffeine
|
DSBs, okadaic acid
|
|
|
inhibit treatment-induced increase
|
|
|
KU-55933
|
DSBs, okadaic acid
|
|
|
no effect upon treatment-induced increase
|
|
|
NU7026
|
DSBs, okadaic acid
|
|
|
no effect upon treatment-induced increase
|
|
|
|
Downstream Regulation
|
|
Effect of modification (function):
molecular association, regulation
|
|
Modification regulates interactions with:
|
|
Interacting molecule
|
Interacting domains
|
Effect
|
Consequences (function)
|
Consequences (process)
|
Detection assays
|
|
DNA
|
|
Disrupts
|
|
|
|
|